Clinicopathological Prognostic Factors After Hepatectomy for Patients with Mass-Forming Type Intrahepatic Cholangiocarcinoma: Relevance of the Lymphatic Invasion Index

Department of Surgery and Sciences, Kyushu University, Fukuoka, Japan.
Annals of Surgical Oncology (Impact Factor: 3.93). 02/2010; 17(7):1816-22. DOI: 10.1245/s10434-010-0929-z
Source: PubMed


The present study was conducted to clarify the pathological factors in patients who underwent surgery for mass-forming type intrahepatic cholangiocarcinoma (IHC).
From 1982 to July 2004, a total of 60 liver resections for mass-forming type IHC were performed at Kyushu University and its affiliated institutions. Portal venous, lymphatic, hepatic venous, and serosal invasion was examined by univariate and multivariate analyses for their prognostic value. The portal venous (PV) invasion index was defined as follows: PV0, portal venous invasion (-) and intrahepatic metastasis (-); PV1, portal venous invasion (+) or intrahepatic metastasis (+); PV2, portal venous invasion (+) and intrahepatic metastasis (+). The lymphatic invasion (LI) index was defined as follows: LI0, lymphatic duct invasion (-) and lymph node metastasis (-); LI1, intrahepatic lymphatic duct invasion (+) or lymph node metastasis (+); LI2, intrahepatic lymphatic duct invasion (+) and lymph node metastasis (+).
In univariate analysis, statistically significant prognostic factors for poor outcome were tumor size (>5 cm), serosal invasion (+), PV1 or PV2, LI1 or LI2, histological grade (moderate and poor), hepatic venous invasion (+) and noncurative resection. After multivariate analysis, the lymphatic invasion index and histological grade were statistically independent prognostic factors for overall survival and recurrence-free survival.
In patients with mass-forming type IHC, lymphatic invasion is the most important invasion pathway, compared with serosal and portal and hepatic venous invasion. Stratification of the lymphatic invasion pathway by lymphatic invasion, including intrahepatic lymphatic duct invasion and lymph node metastasis, is a good predictor for prognosis in patients after hepatectomy for mass-forming type IHC.

7 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: This computer model was commissioned by the Tower Environs Partnership as part of the technical studies to underpin proposed enhancement of the surroundings of the Tower of London. It is intended to provide a sufficiently fine-grained photo-realistic facsimile to allow fine judgement of minor changes in landscape detail. Its credibility is underpinned by close correspondence to the original survey data and by the ability to compare viewpoints with matching photographs taken on site. These models enable examination of the visual impact of both the Tower Environs Scheme proposals and of projected neighbouring schemes which may affect its setting in the future. Future development of the model is proposed to enable change to be experienced before it is committed, to explore different interpretations of historic evidence, and to forge stronger links to other sources of information. In this way, the model can be used as a unified way of finding out more about the Tower and its surroundings, both in the present and in the past. Through these means a much wider and more varied range of people can gain from using the model, increasing the justification for the resources involved in keeping it up to date
    Information Visualization, 1997. Proceedings., 1997 IEEE Conference on; 09/1997
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The seventh TNM edition introduced a new, specific staging structure for intrahepatic cholangiocarcinoma (IHC). To compare the accuracy of the sixth and the new seventh edition to predict survival after hepatectomy for IHC. In all, 434 consecutive patients who underwent hepatectomy at 16 tertiary-care centres (1990-2008) were identified. End points were overall (OS) and recurrence-free survival (RFS) for both T cohorts and stage strata. After a median follow-up of 32.4 months, 3- and 5-year OS and RFS estimates were 47.1% and 32.9%, and 26.5% and 19.1%, respectively. Overall, both the editions were statistically significant discriminators of OS and RFS (P < 0.05). However, the survival curves of the new T2a and T2b cohorts appear superimposed. Conversely, the old T2 and T3 cohorts accurately stratify patients into distinct prognostic groups (P < 0.01). The seventh edition does not show monotonicity of gradients (the T4 category demonstrates significantly better OS and RFS compared with T2 patients). The seventh edition stage I and II are significantly different whereas the old stage I and II were not. The new seventh edition of the AJCC/UICC Staging System proved to be adequate although further studies are need to confirm its superiority compared with the previous edition.
    HPB 03/2011; 13(3):198-205. DOI:10.1111/j.1477-2574.2010.00271.x · 2.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Current criteria for orthotopic liver transplantation (OLT) for cholangiocarcinoma (CCA) remain restricted to early stage and small hilar tumors, excluding patients with locally advanced intrahepatic and hilar CCA for potential cure. The present study was undertaken to define a prognostic scoring system for risk stratification of patients with intrahepatic and hilar CCA who might benefit from OLT and to allow expansion of current OLT criteria. We conducted a retrospective review of 40 patients who underwent OLT for locally advanced intrahepatic and hilar CCA at our center between February 1985 and June 2010. Median follow-up was 3 years. Independent risk factors for tumor recurrence after OLT were identified using the Cox model and were assigned risk score points. Points were summed and assigned to predictive index categories: 0 to 3 for low risk, 4 to 7 for intermediate risk, and 8 to 15 for high risk. Seven multivariate factors predictive for tumor recurrence included multifocal tumor, perineural invasion, infiltrative growth pattern, lack of neoadjuvant and adjuvant therapy, history of primary sclerosing cholangitis, hilar tumors, and lymphovascular invasion. The 5-year tumor recurrence-free patient survival was significantly higher in low-risk (78%) compared with intermediate- (19%) and high-risk (0%) groups (p < 0.001); survival benefit was also seen in intermediate- compared with high-risk groups. This model was highly predictive of long-term outcomes after OLT for locally advanced intrahepatic and hilar CCA and can be applied clinically for risk stratification of patients considered for OLT. Long-term disease recurrence-free survival was excellent in low-risk and acceptable in intermediate-risk groups, justifying the expansion of liver transplant criteria for treatment of this challenging malignancy.
    Journal of the American College of Surgeons 04/2011; 212(4):514-20; discussion 520-1. DOI:10.1016/j.jamcollsurg.2010.12.005 · 5.12 Impact Factor
Show more